PubRank

H J Rogers

Author PubWeight™ 194.53‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Role of iron in bacterial infection. Curr Top Microbiol Immunol 1978 5.92
2 Bacterial growth and the cell envelope. Bacteriol Rev 1970 5.49
3 Iron-binding proteins in milk and resistance to Escherichia coli infection in infants. Br Med J 1972 5.14
4 Autolytic enzyme-deficient mutants of Bacillus subtilis 168. J Bacteriol 1976 4.17
5 Autolytic enzymes in growth of bacteria. Nature 1971 3.63
6 Role of autolysins in the killing of bacteria by some bactericidal antibiotics. J Bacteriol 1971 3.24
7 Cell wall or membrane mutants of Bacillus subtilis and Bacillus licheniformis with grossly deformed morphology. Nature 1968 3.18
8 The abolition of the protective effect of Clostridium welchii type A antiserum by ferric iron. Immunology 1967 2.89
9 Bacterial iron metabolism and immunity to Pasteurella septica and Escherichia coli. Nature 1969 2.87
10 The effect of iron compounds on the virulence of Escherichia coli for guinea-pigs. Immunology 1968 2.83
11 SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts. Leukemia 2011 2.82
12 Some enzymic activities and chemical properties of the mesosomes and cytoplasmic membranes of Bacillus licheniformis 6346. Biochem J 1969 2.56
13 The abolition of the protective effect of Pasteurella septica antiserum by iron compounds. Immunology 1968 2.50
14 The isolation and characterization of mutants of Bacillus subtilis and Bacillus licheniformis with disturbed morphology and cell division. J Gen Microbiol 1970 2.27
15 Isolation and characterization of cell wall-defective variants of Bacillus subtilis and Bacillus licheniformis. J Bacteriol 1973 2.09
16 Bacteriostatic effects of horse sera and serum fractions on Clostridium welchii Type A, and the abolition of bacteriostasis by iron salts. Immunology 1967 2.08
17 The bacteriostatic effect of serum on Pasteurella septica and its abolition by iron compounds. Immunology 1971 2.06
18 Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 1982 2.05
19 Effect of phosphate limitation on the morphology and wall composition of Bacillus licheniformis and its phosphoglucomutase-deficient mutants. J Bacteriol 1973 1.96
20 Plasma prednisolone levels from enteric and non-enteric coated tablets estimated by an original technique. Br J Clin Pharmacol 1977 1.82
21 Rapid DNA extraction from ferns for PCR-based analyses. Biotechniques 1999 1.81
22 Rifampicin reduces effectiveness and bioavailability of prednisolone. Br Med J (Clin Res Ed) 1983 1.79
23 Organization of polymers in the cell walls of some bacilli. Nature 1968 1.79
24 The inhibition of mucopeptide synthesis by benzylpenicillin in relation to irreversible fixation of the antibiotic by staphylococci. Biochem J 1967 1.79
25 Mapping of rod mutants of Bacillus subtilis. J Bacteriol 1972 1.79
26 Ferric iron and the antibacterial effects of horse 7S antibodies to Escherichia coli O111. Immunology 1976 1.60
27 Is repeated flushing of Hickman catheters necessary? Br Med J (Clin Res Ed) 1985 1.57
28 Iron compounds and resistance to infection. Further experiments with Clostridium welchii type A in vivo and in vitro. Immunology 1970 1.53
29 Characterization of Bacillus licheniformis 6346 mutants which have altered lytic enzyme activities. J Bacteriol 1974 1.45
30 Pharmacokinetics and protein binding interactions of dapsone and pyrimethamine. Br J Clin Pharmacol 1980 1.45
31 Biogenesis of the wall in bacterial morphogenesis. Adv Microb Physiol 1979 1.40
32 Modification of the appearance of mesosomes in sections of Bacillus licheniformis according to the fixation procedures. J Ultrastruct Res 1970 1.40
33 Purification and properties of autolytic endo-beta-N-acetylglucosaminidase and the N-acetylmuramyl-L-alanine amidase from Bacillus subtilis strain 168. J Gen Microbiol 1984 1.37
34 Three-dimensional molecular models of bacterial cell wall mucopeptides (peptidoglycans). Proc Natl Acad Sci U S A 1971 1.36
35 Comparative effectiveness of professional and paraprofessional helpers. Psychol Bull 1984 1.35
36 Effects of stimulus parameters on cognitive side effects. Ann N Y Acad Sci 1986 1.31
37 Characterization of a tobacco gene encoding a pollen-specific polygalacturonase. Plant Mol Biol 1994 1.29
38 Mucopeptide synthesis by rod mutants of Bacillus subtilis. J Gen Microbiol 1974 1.28
39 Magnesium and anion requirements of rodB mutants of Bacillus subtilis. J Bacteriol 1976 1.26
40 Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography. Cancer Chemother Pharmacol 1978 1.22
41 Bacteriostatic effect of human milk on Escherichia coli: the role of IgA. Immunology 1978 1.22
42 Plasma and salivary pharmacokinetics of dapsone estimated by a thin layer chromatographic method. Eur J Clin Pharmacol 1980 1.22
43 The chemistry of the cell walls of rod mutants of Bacillus subtilis. J Gen Microbiol 1971 1.21
44 Iron binding proteins and infection. Br J Haematol 1972 1.21
45 The role of L-glutamine in the phenotypic change of a rod mutant derived from Bacillus subtilis 168. J Gen Microbiol 1970 1.20
46 Iron-binding catechols and virulence in Escherichia coli. Infect Immun 1973 1.17
47 Abolition of passive immunity to bacterial infections by iron. Nature 1967 1.15
48 Formation of cell wall polymers by reverting protoplasts of Bacillus licheniformis. J Bacteriol 1975 1.15
49 Effect of cimetidine on the absorption of orally administered tetracycline. Br J Clin Pharmacol 1980 1.14
50 Pharmacokinetics of intravenous and oral prednisolone. Br J Clin Pharmacol 1980 1.13
51 An evaluation of 18S rDNA approaches for the study of fungal diversity in grassland soils. Microb Ecol 2004 1.13
52 Comparative transport activity of intact cells, membrane vesicles, and mesosomes of Bacillus licheniformis. J Bacteriol 1973 1.12
53 Pharmacokinetics of cyclophosphamide and alkylating activity in man after intravenous and oral administration. Br J Clin Pharmacol 1979 1.11
54 Ultrastructural study of the reversion of protoplasts of Bacillus licheniformis to bacilli. J Bacteriol 1975 1.10
55 Peptidoglycans (mucopeptides): structure, function, and variations. Ann N Y Acad Sci 1974 1.09
56 The structure and development of mesosomes studied in Bacillus licheniformis strain 6346. J Ultrastruct Res 1972 1.09
57 Diversity, genetic structure and evidence of outcrossing in British populations of the rock fern Adiantum capillus-veneris using microsatellites. Mol Ecol 2001 1.07
58 Partial characterization of the Nicotiana tabacum actin gene family: evidence for pollen-specific expression of one of the gene family members. Mol Gen Genet 1993 1.07
59 Genetic transfer of the stable L form state to intact bacterial cells. Nature 1973 1.07
60 Bacteriostatic effect of serum: role of antibody to lipopolysaccharide. Infect Immun 1980 1.07
61 Intracellular location of the autolytic N-acetylmuramyl-L-alanine amidase in Bacillus subtilis 168 and in an autolysis-deficient mutant by immunoelectron microscopy. J Bacteriol 1991 1.07
62 A rapid method for determination of acetylation phenotype using dapsone. Br J Clin Pharmacol 1984 1.07
63 Wall and membrane growth in bacilli and their mutants. Ann Microbiol (Paris) 1974 1.05
64 Plasma and salivary pharmacokinetics of caffeine in man. Eur J Clin Pharmacol 1981 1.04
65 Double mutants of Bacillus subtilis growing as helices. J Bacteriol 1978 1.04
66 Production of enterochelin by Escherichia coli 0111. Biochim Biophys Acta 1977 1.04
67 Effects of psychotropic drugs on the erythrocyte permeability to glucose and ethylidene glucose. Biochem Pharmacol 1972 1.02
68 Pharmacokinetics of intravenous glibenclamide investigated by a high performance liquid chromatographic assay. Diabetologia 1982 1.00
69 Selective extraction of polymers from cell walls of gram-positive bacteria. Biochem J 1973 1.00
70 A maize pectin methylesterase-like gene, ZmC5, specifically expressed in pollen. Plant Mol Biol 1998 0.99
71 Antibacterial effect of the scandium and indium complexes of enterochelin on Escherichia coli. J Gen Microbiol 1982 0.98
72 Observations on salicyl hydroxamic acid, an experimental trypanocide. Experientia 1981 0.98
73 Autolysins and shape change in rodA mutants of Bacillus subtilis. J Bacteriol 1978 0.97
74 Morphological and cell wall alterations in thermosensitive DNA mutants of Bacillus subtilis. Ann Inst Pasteur Microbiol 1985 0.95
75 The critical role of iron in some clinical infections. Eur J Clin Microbiol Infect Dis 1991 0.94
76 Decreased systemic clearance of caffeine due to cimetidine. Br J Clin Pharmacol 1981 0.93
77 Pharmacokinetic investigation of the absorption of oxprenolol from Oros delivery systems in healthy volunteers: comparison of in vivo and in vitro drug release. Br J Clin Pharmacol 1985 0.92
78 ORG 10172: a low molecular weight heparinoid anticoagulant with a long half-life in man. Br J Clin Pharmacol 1987 0.91
79 Iron, plasmids and infection. Nature 1980 0.91
80 Effect of cimetidine on oral absorption of ampicillin and cotrimoxazole. J Antimicrob Chemother 1980 0.91
81 Malabsorption of prednisolone from enteric-coated tablets after ileostomy. Br Med J 1980 0.91
82 Iron and infection: new developments and their implications. J Trauma 1996 0.91
83 Pharmacokinetic observations on dapsone in dermatitis herpetiformis. Br J Dermatol 1983 0.90
84 Fractionated ifosfamide therapy produces a time-dependent increase in ifosfamide metabolism. Br J Clin Pharmacol 1990 0.89
85 Effects of concurrent administration of other substrates of N-acetyltransferase on dapsone acetylation. Br J Clin Pharmacol 1981 0.89
86 Temperature-sensitive nature of the rodB maturation in Bacillus subtilis. J Bacteriol 1978 0.89
87 Estimation of mesna and dimesna in plasma and urine by high-performance liquid chromatography with electrochemical detection. J Chromatogr 1986 0.89
88 Comparison of radioimmunoassay and thin layer chromatographic assay methods for estimation of plasma prednisolone concentrations. J Pharmacol Methods 1981 0.88
89 The Arabidopsis CDC25 induces a short cell length when overexpressed in fission yeast: evidence for cell cycle function. New Phytol 2005 0.88
90 Antibacterial effect of scandium and indium complexes of enterochelin on Klebsiella pneumoniae. Antimicrob Agents Chemother 1980 0.88
91 Pharmacokinetics of intravenous and oral sodium 2-mercaptoethane sulphonate (mesna) in normal subjects. Br J Clin Pharmacol 1987 0.87
92 The bactericidal action of beta-lactam antibiotics on an autolysin-deficient strain of Bacillus subtilis. J Gen Microbiol 1983 0.87
93 Antagonism between vegetative cells and L-forms of Bacillus licheniformis strain 6346. Nature 1966 0.86
94 The organisation of the polymers in Gram-positive and Gram-negative bacteria. J Gen Microbiol 1969 0.86
95 Methylprednisolone pharmacokinetics after intravenous and oral administration. Br J Clin Pharmacol 1989 0.86
96 The clinical pharmacology of acyclovir. J Clin Hosp Pharm 1983 0.86
97 Concurrent administration of cimetidine and enteric-coated prednisolone: effect on plasma levels of prednisolone. Br J Clin Pharmacol 1980 0.85
98 Pharmacokinetic observations on piroxicam in young adult, middle-aged and elderly patients. Br J Clin Pharmacol 1983 0.85
99 Effect of folate and folinate on 3H-thymidine incorporation by transforming human lymphocytes in vitro. Experientia 1977 0.84
100 Possible intermediates in the biosynthesis of mycoside B by Mycobacterium microti. Eur J Biochem 1993 0.84
101 Neurobehavioral functioning in a nonconfounded group of asymptomatic HIV-seropositive homosexual men. Am J Psychiatry 1992 0.84
102 The pharmacokinetics of cyclophosphamide, phosphoramide mustard and nor-nitrogen mustard studied by gas chromatography in patients receiving cyclophosphamide therapy. Br J Clin Pharmacol 1980 0.83
103 Separable polymers in bacterial cell walls. Br Med Bull 1966 0.83
104 Effect of pirprofen on glibenclamide kinetics and response. Br J Clin Pharmacol 1982 0.83
105 The influence of cimetidine on debrisoquine 4-hydroxylation in extensive metabolizers. Eur J Clin Pharmacol 1989 0.82
106 The killing of bacteria by cell wall inhibitors. Contrib Microbiol Immunol 1973 0.82
107 Influence of age, sex and body weight on the dapsone acetylation phenotype. Br J Clin Pharmacol 1987 0.81
108 Effect of renal insufficiency on the pharmacokinetics of cyclophosphamide and some of its metabolites. Eur J Clin Pharmacol 1981 0.81
109 Cadmium stress alters gene expression of DNA mismatch repair related genes in Arabidopsis seedlings. Chemosphere 2008 0.80
110 An analysis of the relative activities of a number of promoter constructs from genes which are expressed during late pollen development as determined by particle bombardment. Plant Cell Rep 1995 0.80
111 Comparison of thin-layer and gas chromatographic assays for caffeine in plasma. J Chromatogr 1979 0.79
112 Antibacterial effect of the scandium complex of enterochelin. Studies of the mechanism of action. Biochim Biophys Acta 1983 0.79
113 Genetically determined debrisoquine oxidation capacity in bladder cancer. Carcinogenesis 1984 0.79
114 The kinetics of salivary elimination of cyclophosphamide in man. Br J Clin Pharmacol 1979 0.79
115 Differential expression of putative floral genes in Pharbitis nil shoot apices cultured on glucose compared with sucrose. J Exp Bot 2004 0.79
116 Determination of debrisoquine metabolic ratio from hourly urine collections in healthy volunteers. Br J Clin Pharmacol 1987 0.79
117 The pharmacokinetics of ifosfamide given as short and long intravenous infusions in cancer patients. Br J Clin Pharmacol 1991 0.79
118 Effects of single and multiple doses of ketoconazole on adrenal function in normal subjects. Br J Clin Pharmacol 1985 0.78
119 Acetylation and oxidation phenotypes in malignant lymphoma. Cancer Chemother Pharmacol 1987 0.78
120 Observations on the pharmacokinetics of low dose aminoglutethimide in patients with advanced breast cancer. Br J Cancer 1985 0.78
121 Rapid gas chromatographic determination of ifosfamide in biological fluids. J Chromatogr 1984 0.78
122 The effect of co-trimoxazole on thymidine uptake by transforming human lymphocytes in vitro. J Pharm Pharmacol 1976 0.78
123 Pharmacokinetics of single doses of sulphinpyrazone and its major metabolites in plasma and urine. Br J Clin Pharmacol 1982 0.78
124 The role of Eh, pH and iron in the bactericidal power of human plasma. FEMS Microbiol Lett 1992 0.78
125 Studies of the antibacterial effect of the scandium complex of enterochelin. J Antibiot (Tokyo) 1984 0.78
126 Pharmacokinetics of melphalan in children following high-dose intravenous injection. Cancer Chemother Pharmacol 1983 0.78
127 Kinetics of single doses of fenbufen in patients with renal insufficiency. Clin Pharmacol Ther 1981 0.78
128 Ethylene induces cell death at particular phases of the cell cycle in the tobacco TBY-2 cell line. J Exp Bot 2001 0.77
129 Phenytoin intoxication during concurrent diazepam therapy. J Neurol Neurosurg Psychiatry 1977 0.77
130 Biliary elimination of cyclophosphamide in man. Cancer Chemother Pharmacol 1982 0.77
131 Prednisolone elimination in human saliva. Int J Clin Pharmacol Ther Toxicol 1985 0.77
132 Effect of haemoglobin on experimental infections with Pasteurella septia and Escherichia coli. Nature 1968 0.77
133 The effect of acetylator phenotype on the disposition of aminoglutethimide. Br J Clin Pharmacol 1984 0.77
134 Effect of food on the absorption and pharmacokinetics of prednisolone from enteric-coated tablets. Eur J Clin Pharmacol 1989 0.77
135 The effects of ECT modifications on autobiographical and verbal memory. Biol Psychiatry 1982 0.77
136 Ifosfamide plasma clearance in relation to polymorphic debrisoquine oxidation. Cancer Chemother Pharmacol 1988 0.77
137 Polymorphic N-acetylation capacity in lung cancer. Carcinogenesis 1988 0.76
138 A rapid method for the determination of plasma mexiletine levels by gas chromatography. Br J Clin Pharmacol 1977 0.76
139 Pharmacokinetics of idarubicin (4-demethoxydaunorubicin; IMI-30; NSC 256439) following intravenous and oral administration in patients with advanced cancer. Br J Clin Pharmacol 1987 0.76
140 The determination time of the carpel whorl is differentially sensitive to carbohydrate supply in Pharbitis nil. Plant Physiol 2000 0.76
141 Expression of fission yeast cdc25 driven by the wheat ADP-glucose pyrophosphorylase large subunit promoter reduces pollen viability and prevents transmission of the transgene in wheat. New Phytol 2005 0.76
142 The structure and biosynthesis of the components of the cell walls of gram-positive bacteria. Folia Microbiol (Praha) 1967 0.76
143 Effects of electroconvulsive therapy upon brain electrical activity. Ann N Y Acad Sci 1986 0.76
144 Acetylator status and its relationship to breast cancer and other diseases of the breast. Eur J Cancer Clin Oncol 1987 0.75
145 The half-life of amitriptyline. Br J Clin Pharmacol 1978 0.75
146 Salivary elimination of pyrimethamine. Br J Clin Pharmacol 1981 0.75
147 Distribution and pharmacokinetics of cyclophosphamide in the rat. Br J Cancer 1980 0.75
148 Comparison of the effect of drugs upon some commonly used measures of bowel transit time. Br J Clin Pharmacol 1978 0.75
149 Can once daily dosage be effective in the treatment of hypertension throughout 24 hours? A controlled evaluation of sustained release oxprenolol. Br J Clin Pharmacol 1979 0.75
150 Further effects of chlorpromazine on the hexose permeability of the human erythrocyte. J Physiol 1973 0.75
151 Failure of bupropion to affect the response to tyramine in man. Br J Clin Pharmacol 1981 0.75
152 Plasma cinnarizine levels resulting from oral administration as capsule or tablet formulation investigated by gas-liquid chromatography. Br J Clin Pharmacol 1979 0.75
153 Confidence intervals for pharmacokinetic parameters [proceedings]. Br J Pharmacol 1978 0.75
154 Comparison of pharmacokinetic profiles of single and multiple doses of a slow release Oros oxprenolol delivery system in young normotensive and elderly hypertensive subjects. Br J Clin Pharmacol 1986 0.75
155 The effect of bromelain on the absorption of orally administered tetracycline. Br J Clin Pharmacol 1978 0.75
156 The hypotensive response to hydralazine, in triple therapy, is not related to acetylator phenotype. Br J Clin Pharmacol 1982 0.75
157 Effect of chlorpromazine on hexose penetration in the human erythrocyte. Br J Pharmacol 1973 0.75
158 Enhanced absorption of salicylate from Safapyryn-Co tablets. Br J Clin Pharmacol 1979 0.75
159 The inhibition of fatty acid elongation by pebulate can be effectively counteracted by the safener dichlormid. Biochem Soc Trans 2000 0.75
160 Urinary excretion of prednisolone following intravenous administration in humans. J Clin Pharmacol 1989 0.75
161 First pass hepatic metabolism of cyclophosphamide [proceedings]. Br J Clin Pharmacol 1979 0.75
162 Inhibition by trimethoprim of some effects of epidermal growth factor on human fibroblasts in tissue culture. Biochem Pharmacol 1976 0.75
163 The effects of domperidone on the absorption of levodopa in normal subjects. Eur J Clin Pharmacol 1986 0.75
164 Uroepithelial and nephrotubular toxicity in patients receiving ifosfamide/mesna: measurement of urinary N-acetyl-beta-D-glucosaminidase and beta-2-microglobulin. Eur J Cancer 1992 0.75
165 Three-dimensional molecular models of the mucopeptide from Staphylococcus aureus. J Gen Microbiol 1969 0.75
166 Morphological changes in Bacillus subtilis with genetic and phenotypic origins. Ann Inst Pasteur Microbiol 1985 0.75
167 Effect of paracetamol on amylobarbitone hydroxylation in man: a gas chromatographic method for simultaneous estimation of underivatized paracetamol and barbiturates. J Pharm Pharmacol 1979 0.75
168 Bioavailability of phenylbutazone from a new enteric-coated formulation with superior dissolution characteristics. Biopharm Drug Dispos 1982 0.75
169 Very high molecular weight mucopolysaccharides and mucopolysaccharide-protein complexes--how far can we extrapolate? Fed Proc 1966 0.75
170 Interaction of cimetidine with tetracycline absorption. Lancet 1980 0.75
171 THE SIGNIFICANCE AND VALUE OF THE LANGE GOLDSOL REACTION IN DISSEMINATED SCLEROSIS. J Neurol Psychopathol 1932 0.75
172 High-performance liquid chromatographic assay for simultaneous estimation of aminoglutethimide and acetylaminoglutethimide in biological fluids. Cancer Chemother Pharmacol 1985 0.75
173 Short Notes and Clinical Cases: THE QUESTION OF SILVER CELLS AS PROOF OF THE SPIROCHÆTAL THEORY OF DISSEMINATED SCLEROSIS. J Neurol Psychopathol 1932 0.75
174 Plasma mexiletine concentrations following combined oral and intramuscular administration. Eur J Clin Pharmacol 1981 0.75
175 Relationship between hypothermia and some chlorpromazine induced metabolic changes in mouse brain. Experientia 1972 0.75
176 The in vitro effect of trimethoprim on blastogenic transformation of human peripheral blood lymphocytes. Biochem Pharmacol 1977 0.75
177 Bacterial iron metabolism and resistance to infection. J Med Microbiol 1970 0.75
178 Gas--liquid chromatographic assay of aminoglutethimide and a high-performance liquid chromatographic assay for its acetyl metabolite in biological fluids. J Chromatogr 1984 0.75
179 A preliminary controlled evaluation of the antihypertensive effect of indapamide. Curr Med Res Opin 1977 0.75
180 The reactions of streptococci and lactobacilli in blood agar. J Hyg (Lond) 1939 0.75
181 Iron, infection, and the role of bicarbonate. FEMS Microbiol Lett 1990 0.75
182 Effect of osmotic shock and shearing forces on ferric enterochelin transport in Escherichia coli K12. J Gen Microbiol 1987 0.75
183 Plasma melphalan and prednisolone concentrations during oral therapy for multiple myeloma. Cancer Chemother Pharmacol 1982 0.75
184 Effect of cancer chemotherapy on dapsone N-acetylation in man. Cancer Chemother Pharmacol 1989 0.75
185 Pharmacokinetics of single and multiple doses of flusoxolol (Ro 31-1411) in healthy subjects. Eur J Clin Pharmacol 1986 0.75
186 N-Acetyltransferase phenotypes in Iraqi and British population. Hum Hered 1984 0.75
187 A meta-analysis of frontalis EMG levels with biofeedback and alternative procedures. Biofeedback Self Regul 1984 0.75
188 Failure of bupropion to affect tyramine response in man. J Clin Psychiatry 1983 0.75
189 The effects of flurbiprofen and indomethacin on the mitogenic response of human peripheral mononuclear cells. Immunopharmacology 1984 0.75
190 Non-linear pharmacokinetic behaviour of dapsone in the rabbit. J Pharm Pharmacol 1981 0.75
191 Two chromatographic methods for the determination of corticosteroids in human biological fluids: pharmacokinetic applications. J Pharm Sci 1989 0.75
192 The relative bioavailability of paracetamol after rectal administration of suppositories containing a mixture of paracetamol, codeine phosphate and buclizine hydrochloride in healthy volunteers. Curr Med Res Opin 1985 0.75
193 Naive versus sophisticated item-writers for the assessment of anxiety. J Clin Psychol 1985 0.75
194 The influence of aromatic amines and folate on acid production by Escherichia coli. Experientia 1978 0.75
195 Effect of cimetidine on the absorption and efficacy of orally administered furosemide. Int J Clin Pharmacol Ther Toxicol 1982 0.75
196 The involvement of proteases in the morphogenesis of rod mutants of Bacillus subtilis. FEBS Lett 1980 0.75
197 Infections and iron. Am J Dis Child 1981 0.75
198 Comparative steady state pharmacokinetic study of piroxicam and flurbiprofen in normal subjects. Eur J Rheumatol Inflamm 1981 0.75
199 The influence of hypothermia on chlorpromazine-induced metabolic changes in mouse heart and brain. J Pharm Pharmacol 1971 0.75
200 Food & medicine incompatibility. R Soc Health J 1982 0.75
201 A study of repeated administration of fenbufen in patients with chronic rheumatic disorders and renal impairment. Eur J Rheumatol Inflamm 1982 0.75
202 Melphalan estimation by quantitative thin-layer chromatography. Observations on melphalan hydrolysis in vitro and pharmacokinetics in rabbits. Cancer Chemother Pharmacol 1981 0.75
203 Iron, trauma and infection. Eur J Clin Microbiol Infect Dis 1993 0.75